Avenue Therapeutics, Inc. (NASDAQ:ATXI) Director Buys $251,046.00 in Stock

Avenue Therapeutics, Inc. (NASDAQ:ATXI – Get Free Report) Director Lindsay A. Md Rosenwald purchased 348,675 shares of the company’s stock in a transaction dated Friday, September 8th. The shares were bought at an average cost of $0.72 per share, for a total transaction of $251,046.00. Following the acquisition, the director now owns 354,318 shares in […]

Related Keywords

United States , ,Renaissance Technologies ,Geode Capital Management ,Nasdaq ,Virtu Financial ,Avenue Therapeutics Company Profile ,Avenue Therapeutics Inc ,Avenue Therapeutics ,Get Free Report ,Director Lindsay ,Street Corp ,Capital Management ,Two Sigma Investments ,Avenue Therapeutics Daily ,Nasdaq Atxi ,Patxi ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,